The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
Open accessAbstract
DNA methylation at the 5 position of cytosine (5-mC) is a key epigenetic mark that is critical for various biological and pathological processes. 5-mC can be converted to 5-hydroxymethylcytosine (5-hmC) by the ten-eleven translocation (TET) family of DNA hydroxylases. Here, we report that "loss of 5-hmC" is an epigenetic hallmark of melanoma, with diagnostic and prognostic implications. Genome-wide mapping of 5-hmC reveals loss of the 5-hmC landscape in the melanoma epigenome. We show that downregulation of isocitrate dehydrogenase 2 (IDH2) and TET family enzymes is likely one of the mechanisms underlying 5-hmC loss in melanoma. Rebuilding the 5-hmC landscape in melanoma cells by reintroducing active TET2 or IDH2 suppresses melanoma growth and increases tumor-free survival in animal models. Thus, our study reveals a critical function of 5-hmC in melanoma development and directly links the IDH and TET activity-dependent epigenetic pathway to 5-hmC-mediated suppression of melanoma progression, suggesting a new strategy for epigenetic cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whereas its downregulation leads to epigenetic dysfunction via the loss of 5-hydroxymethyl-cytosine in melanoma (Lian et al., 2012).”
From SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways (2013) · cites this paper as Lian et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Jemal, A., Siegel, R. L., Ward, E. M., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,309
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
Self-citationIto, S., D’Alessio, A. C., Taranova, O., Hong, K., Sowers, L. C., & Zhang, Y. (2010) · Nature · doi:10.1038/nature09303 · Cited by 2,628
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020 · cited 2×
“These data suggest that IDH2, but not IDH1, is specifically downregulated in melanomas and that the WT IDH2 acts as a putative tumor suppressor in the zebrafish melanoma model, although the IDH family of enzymes has been considered candidate oncogenes in various tumors (Ward et al., 2010; Wrzeszczynski et al., 2011).”
BackgroundMutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776
Identification of cells initiating human melanomas
Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., et al. (2008) · Nature · doi:10.1038/nature06489 · Cited by 1,449
Self-citationDynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation
Ficz, G., Branco, M. R., Seisenberger, S., Santos, F., Krueger, F., Hore, T. A., Marques, C. J., Andrews, S., & Reik, W. (2011) · Nature · doi:10.1038/nature10008 · Cited by 1,160
Cited by
Sorted by citations
TET-mediated active DNA demethylation: mechanism, function and beyond
Wu, X., & Zhang, Y. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.33 · Cited by 1,661
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions
Wu, H., & Zhang, Y. (2014) · Cell · doi:10.1016/j.cell.2013.12.019 · Cited by 1,065
Role of TET enzymes in DNA methylation, development, and cancer
Rasmussen, K. D., & Helin, K. (2016) · Genes & Development · doi:10.1101/gad.276568.115 · Cited by 1,040
“Nonetheless, decreased expression of TET proteins and lower 5hmC levels are general hallmarks of many cancer types, including gastric, prostate, liver, lung, and breast cancer as well as glioblastoma and melanoma (Kudo et al. 2012; Lian et al. 2012; Turcan et al. 2012; Liu et al. 2013a; Yang et al. 2013).”
BackgroundSIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways
Park, J., Chen, Y., Tishkoff, D. X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B. M. M., Skinner, M. E., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.001 · Cited by 1,000
Navigating the DNA methylation landscape of cancer
Nishiyama, A., & Nakanishi, M. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.05.002 · Cited by 1,001
TETonic shift: biological roles of TET proteins in DNA demethylation and transcription
Pastor, W. A., Aravind, L., & Rao, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3589 · Cited by 897
Xiang, Y., Guo, Z., Zhu, P., Chen, J., & Huang, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2108 · Cited by 760
The Roles of Vitamin C in Skin Health.
Pullar, J., Carr, A., & Vissers, M. (2017) · Nutrients · doi:10.3390/nu9080866 · Cited by 756
“Aberrant epigenetic alterations are thought to have a role in cancer progression, and there is data to suggest that a loss of 5 hmC occurs during the early development and progression of melanoma [114].”
Backgroundm6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
Yang, S., Wei, J., Cui, Y., Park, G., Shah, P., Deng, Y. L., Aplin, A. E., Lu, Z., Hwang, S., He, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10669-0 · Cited by 756
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
Timp, W., & Feinberg, A. P. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3486 · Cited by 611
5-Hydroxymethylcytosine is a predominantly stable DNA modification
Bachman, M., Uribe‐Lewis, S., Yang, X., Williams, M., Murrell, A., & Balasubramanian, S. (2014) · Nature Chemistry · doi:10.1038/nchem.2064 · Cited by 577
Genome-wide Profiling of 5-Formylcytosine Reveals Its Roles in Epigenetic Priming
Song, C., Szulwach, K. E., Dai, Q., Fu, Y., Mao, S.-Q., Lin, L., Street, C., Li, Y., Poidevin, M., Wu, H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.001 · Cited by 562
The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia
Bastian, B. C. (2014) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104658 · Cited by 540
Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
Wu, D., Hu, D., Chen, H., Shi, G., Fetahu, I. S., Wu, F., Rabidou, K., Fang, R., Tan, L., Xu, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0350-5 · Cited by 477
Self-citationCrystal Structure of TET2-DNA Complex: Insight into TET-Mediated 5mC Oxidation
Hu, L., Li, Z., Cheng, J., Rao, Q., Gong, W., Liu, M., Shi, Y. G., Zhu, J., Wang, P., & Xu, Y. (2013) · Cell · doi:10.1016/j.cell.2013.11.020 · Cited by 467
Self-citationMinor, E. A., Court, B. L., Young, J. I., & Wang, G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.464800 · Cited by 413
Cai, Z., Kotzin, J. J., Ramdas, B., Chen, S., Nelanuthala, S., Palam, L. R., Pandey, R., Mali, R. S., Liu, Y., Kelley, M. R., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.013 · Cited by 394
Signal pathways of melanoma and targeted therapy
Guo, W., Wang, H., & Li, C. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00827-6 · Cited by 419
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX
Ko, M., An, J., Bandukwala, H. S., Chávez, L., Äijö, T., Pastor, W. A., Segal, M., Li, H., Koh, K. P., Lähdesmäki, H. J., et al. (2013) · Nature · doi:10.1038/nature12052 · Cited by 414
Cancer Development, Progression, and Therapy: An Epigenetic Overview
Sarkar, S., Horn, G., Moulton, K. L., Oza, A. U., Byler, S., Kokolus, S., & Longacre, M. M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141021087 · Cited by 425
Gene methylation in gastric cancer
Qu, Y., Dang, S., & Hou, P. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.002 · Cited by 376
DNA methylation profiles in cancer diagnosis and therapeutics
Pan, Y., Liu, G., Zhou, F., Su, B., & Li, Y. (2017) · Clinical and Experimental Medicine · doi:10.1007/s10238-017-0467-0 · Cited by 379
Gao, Y., Chen, J., Li, K., Wu, T., Huang, B., Liu, W., Kou, X., Zhang, Y., Huang, H., Jiang, Y., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.02.005 · Cited by 362
Mechanism and Function of Oxidative Reversal of DNA and RNA Methylation
Shen, L., Song, C., He, C., & Zhang, Y. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035513 · Cited by 369
Killian, J. K., Kim, S. Y., Miettinen, M., Smith, C., Merino, M., Tsokos, M., Quezado, M., Smith, W. I., Jahromi, M. S., Xekouki, P., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0092 · Cited by 356
The 2016 World Health Organization classification of tumours of the central nervous system
Villa, C., Miquel, C., Mosses, D., Bernier, M., & Stefano, A. L. D. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.04.015 · Cited by 322
Regulation of the epigenome by vitamin C
Young, J. I., Züchner, S., & Wang, G. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034228 · Cited by 319
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
Petralia, F., Tignor, N., Reva, B., Koptyra, M., Chowdhury, S., Rykunov, D., Krek, A., Ma, W., Zhu, Y., Ji, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.044 · Cited by 317
The DNA methylation landscape in cancer
Skvortsova, K., Stirzaker, C., & Taberlay, P. C. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190037 · Cited by 325
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
Laukka, T., Mariani, C. J., Ihantola, T., Cao, J. Z., Hokkanen, J., Kaelin, W. G., Godley, L. A., & Koivunen, P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.688762 · Cited by 307
Ten-Eleven Translocation-2 (TET2) Is a Master Regulator of Smooth Muscle Cell Plasticity
Liu, R., Yu, J. H., Tang, W. H., Qin, L., Zhang, X., Tellides, G., Hwa, J., Yu, J., & Martin, K. A. (2013) · Circulation · doi:10.1161/circulationaha.113.002887 · Cited by 289
Nucleic Acid Modifications in Regulation of Gene Expression
Chen, K., Zhao, B. S., & He, C. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.11.007 · Cited by 290
Epigenetic regulation in human melanoma: past and future
Sarkar, D., Leung, E. Y., Baguley, B. C., Finlay, G. J., & Askarian-Amiri, M. (2015) · Epigenetics · doi:10.1080/15592294.2014.1003746 · Cited by 299
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
Solary, É., Bernard, O., Tefferi, A., Fuks, F., & Vainchenker, W. (2013) · Leukemia · doi:10.1038/leu.2013.337 · Cited by 298
TET (Ten-eleven translocation) family proteins: structure, biological functions and applications
Zhang, X., Zhang, Y., Wang, C., & Wang, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01537-x · Cited by 297
HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
Sun, M., Song, C., Huang, H., Frankenberger, C. A., Sankarasharma, D., Gomes, S., Chen, P., Chen, J., Chada, K. K., He, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305172110 · Cited by 273
Xu, Y., Xu, C., Kato, A., Tempel, W., Abreu, J. G., Bian, C., Hu, Y., Hu, D., Zhao, B., Cerovina, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.11.014 · Cited by 271
Self-citationRampal, R. K., Akalin, A., Madžo, J., Vasanthakumar, A., Pronier, E., Patel, J. L., Li, Y., Ahn, J., Abdel-Wahab, O. I., Shih, A. H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.004 · Cited by 280
Connections between TET proteins and aberrant DNA modification in cancer
Huang, Y., & Rao, A. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.07.005 · Cited by 274
Breton, C. V., Marsit, C. J., Faustman, E. M., Nadeau, K. C., Goodrich, J. M., Dolinoy, D. C., Herbstman, J. B., Holland, N., LaSalle, J. M., Schmidt, R. J., et al. (2017) · Environmental Health Perspectives · doi:10.1289/ehp595 · Cited by 271
Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells
Huang, Y., Chávez, L., Chang, X., Wang, X., Pastor, W. A., Kang, J., Zepeda-Martínez, J. A., Pape, U. J., Jacobsen, S. E., Peters, B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322921111 · Cited by 272
TET proteins and the control of cytosine demethylation in cancer
Scourzic, L., Mouly, E., & Bernard, O. (2015) · Genome Medicine · doi:10.1186/s13073-015-0134-6 · Cited by 263
Melanocytic nevi and melanoma: unraveling a complex relationship
Damsky, W., & Bosenberg, M. (2017) · Oncogene · doi:10.1038/onc.2017.189 · Cited by 263
BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
Segura, M. F., Fontanals-Cirera, B., Gaziel‐Sovran, A., Guijarro, M. V., Hanniford, D., Zhang, G., González‐Gómez, P., Morante, M., Jubierre, L., Zhang, W., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0122-t · Cited by 247
Zhu, Z., Lee, P. H., Chaffin, M. D., Chung, W., Loh, P., Lu, Q., Christiani, D. C., & Liang, L. (2018) · Nature Genetics · doi:10.1038/s41588-018-0121-0 · Cited by 239
RNA methylation and cancer treatment
Yang, B., Wang, J., Tan, Y., Yuan, R., Chen, Z., & Zou, C. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105937 · Cited by 244
Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
Xu, Y., Lv, L., Liu, Y., Smith, M. D., Li, W., Tan, X. M., Cheng, M., Li, Z., Bovino, M., Aubé, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129317 · Cited by 230
Self-citationNew Insights into 5hmC DNA Modification: Generation, Distribution and Function
Shi, D., Ali, I., Tang, J., & Yang, W. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00100 · Cited by 239
TET1 plays an essential oncogenic role in MLL -rearranged leukemia
Huang, H., Jiang, X., Li, Z., Li, Y., Song, C., He, C., Sun, M., Chen, P., Gurbuxani, S. K., Wang, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310656110 · Cited by 228
The epigenetic role of vitamin C in health and disease
Camarena, V., & Wang, G. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2145-x · Cited by 227
The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution
Nirmal, A. J., Maliga, Z., Vallius, T., Quattrochi, B., Chen, A. A., Jacobson, C. A., Pelletier, R. J., Yapp, C., Arias-Camison, R., Chen, Y., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1357 · Cited by 211
Self-citationThe Pathobiology of Skin Aging
Russell-Goldman, E. E., & Murphy, G. F. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.03.007 · Cited by 224
Self-citationMapping recently identified nucleotide variants in the genome and transcriptome
Song, C., Yi, C., & He, C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2398 · Cited by 202
5-hydroxymethylcytosine and its potential roles in development and cancer
Pfeifer, G. P., Kadam, S., & Jin, S. (2013) · Epigenetics & Chromatin · doi:10.1186/1756-8935-6-10 · Cited by 205
Neri, F., Dettori, D., Incarnato, D., Křepelová, A., Rapelli, S., Maldotti, M., Parlato, C., Paliogiannis, P., & Oliviero, S. (2014) · Oncogene · doi:10.1038/onc.2014.356 · Cited by 194
Driver mutations of cancer epigenomes
Roy, D. M., Walsh, L. A., & Chan, T. A.-T. (2014) · Protein & Cell · doi:10.1007/s13238-014-0031-6 · Cited by 188
The CpG Island Methylator Phenotype: What's in a Name?
Hughes, L., Melotte, V., Schrijver, J. M. D., de Maat, M., Smit, V. T. H. B. M., Bovée, J. V. M. G., French, P. J., van den Brandt, P. A., Schouten, L. J., Meyer, T. D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4306 · Cited by 182
Antioxidant and Anti-Tumor Effects of Dietary Vitamins A, C, and E
Didier, A. J., Stiene, J., Fang, L., Watkins, D., Dworkin, L. D., & Creeden, J. F. (2023) · Antioxidants · doi:10.3390/antiox12030632 · Cited by 204
Neri, F., Incarnato, D., Krepelova, A., Rapelli, S., Pagnani, A., Zecchina, R., Parlato, C., & Oliviero, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-8-r91 · Cited by 179
Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer
Chen, K., Zhang, J., Guo, Z., Ma, Q., Xu, Z., Zhou, Y., Xu, Z., Li, Z., Liu, Y., Ye, X., et al. (2015) · Cell Research · doi:10.1038/cr.2015.150 · Cited by 177
Metabolic rewiring in melanoma
Ratnikov, B. I., Scott, D. A., Osterman, A. L., Smith, J. W., & Ronai, Z. A. (2016) · Oncogene · doi:10.1038/onc.2016.198 · Cited by 176
Mechanisms that regulate the activities of TET proteins
Joshi, K., Liu, S., Breslin, P., & Zhang, J. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04396-x · Cited by 177
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
Micevic, G., Theodosakis, N., & Bosenberg, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0332-8 · Cited by 171
Liu, C., Liu, L., Chen, X., Shen, J., Shan, J., Xu, Y., Yang, Z., Wu, L., Xia, F., Bie, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062828 · Cited by 161
Self-citationAn Extensive Network of TET2-Targeting MicroRNAs Regulates Malignant Hematopoiesis
Cheng, J., Guo, S., Chen, S., Mastriano, S., Liu, C., D’Alessio, A. C., Hysolli, E., Guo, Y., Yao, H., Megyola, C. M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.050 · Cited by 164
Application of immunohistochemistry in diagnosis and management of malignant mesothelioma
Chapel, D. B., Schulte, J. J., Husain, A. N., & Krausz, T. N. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.11.29 · Cited by 155
Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease
Wang, F., Yang, Y., Lin, X., Wang, J.-Q., Yong-sheng, W., Xie, W., Wang, D., Zhu, S., Liao, Y.-Q., Sun, Q., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt214 · Cited by 155
Self-citationOncometabolites‐driven tumorigenesis: From genetics to targeted therapy
Morin, A., Letouzé, É., Gimenez‐Roqueplo, A., & Favier, J. (2014) · International Journal of Cancer · doi:10.1002/ijc.29080 · Cited by 162
Tang, Y., Zheng, S.-J., Qi, C., Feng, Y., & Yuan, B. (2015) · Analytical Chemistry · doi:10.1021/ac504786r · Cited by 144
Takai, H., Masuda, K., Sato, T., Sakaguchi, Y., Suzuki, T., Suzuki, T., Koyama‐Nasu, R., Nasu‐Nishimura, Y., Katou, Y., Ogawa, H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.071 · Cited by 151
Tampe, B., Tampe, D., Müller, C. A., Sugimoto, H., LeBleu, V. S., Xu, X., Muller, G. A., Zeisberg, E. M., Kalluri, R., & Zeisberg, M. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070723 · Cited by 143
Epigenetic regulation of smooth muscle cell plasticity
Liu, R., Leslie, K. L., & Martin, K. A. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.06.004 · Cited by 142
Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis
Wu, M.-Z., Chen, S.-F., Nieh, S., Benner, C. W., Ger, L., Jan, C., Ma, L., Chen, C., Hishida, T., Chang, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3208 · Cited by 136
Tissue-specific 5-hydroxymethylcytosine landscape of the human genome
He, B., Zhang, C., Zhang, X., Fan, Y., Zeng, H., Liu, J., Meng, H., Bai, D., Peng, J., Zhang, Q., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24425-w · Cited by 135
Loss of 5-hydroxymethylcytosine in cancer: Cause or consequence?
Ficz, G., & Gribben, J. G. (2014) · Genomics · doi:10.1016/j.ygeno.2014.08.017 · Cited by 135
Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
Carr, A. C., & Cook, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01182 · Cited by 133
Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene
Fontanals-Cirera, B., Hasson, D., Vardabasso, C., Micco, R. D., Agrawal, P. K., Chowdhury, A. H., Gantz, M., de Pablos-Aragoneses, A., Morgenstern, A., Wu, P., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.11.004 · Cited by 134
Genomic insights into cancer-associated aberrant CpG island hypermethylation
Sproul, D., & Meehan, R. R. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/els063 · Cited by 135
Detection of Human Urinary 5-Hydroxymethylcytosine by Stable Isotope Dilution HPLC-MS/MS Analysis
Yin, R., Mo, J., Lü, M., & Wang, H. (2014) · Analytical Chemistry · doi:10.1021/ac5038895 · Cited by 133
Cytosine-Based TET Enzyme Inhibitors
Chua, G. N. L., Wassarman, K. L., Sun, H., Alp, J. A., Jarczyk, E. I., Kuzio, N. J., Bennett, M. J., Malachowsky, B. G., Kruse, M., & Kennedy, A. J. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00474 · Cited by 135
Vitamin C in Stem Cell Biology: Impact on Extracellular Matrix Homeostasis and Epigenetics
D’Aniello, C., Cermola, F., Patriarca, E. J., & Minchiotti, G. (2017) · Stem Cells International · doi:10.1155/2017/8936156 · Cited by 135
Epigenetics of malignant melanoma
Moran, B., Silva, R., Perry, A. S., & Gallagher, W. M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.006 · Cited by 136
Odagiri, H., Kadomatsu, T., Endo, M., Masuda, T., Morioka, M. S., Fukuhara, S., Miyamoto, T. K., Kobayashi, E., Miyata, K., Aoi, J., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004612 · Cited by 130
Li, L., Li, C., Mao, H., Du, Z., Chan, W., Murray, P. G., Luo, B., Chan, A. T. �., Mok, T. S. K., Chan, F. K. L., et al. (2016) · Scientific Reports · doi:10.1038/srep26591 · Cited by 126
NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity
Wang, L., Song, C., Wang, N., Li, S., Liu, Q., Sun, Z., Wang, K., Yu, S., & Yang, Q. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0601-2 · Cited by 123
Whole-genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liverPreprint
Li, X., Liu, Y., Salz, T., Hansen, K. D., & Feinberg, A. P. (2016) · Genome Research · doi:10.1101/gr.211854.116 · Cited by 119
Skvortsova, K., Masle‐Farquhar, E., Luu, P., Song, J. Z., Qu, W., Zotenko, E., Gould, C. M., Du, Q., Peters, T. J., Colino‐Sanguino, Y., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.004 · Cited by 121
Takayama, K., Misawa, A., Suzuki, T., Takagi, K., Hayashizaki, Y., Fujimura, T., Homma, Y., Takahashi, S., Urano, T., & Inoue, S. (2015) · Nature Communications · doi:10.1038/ncomms9219 · Cited by 121
Playing TETris with DNA modifications
Delatte, B., Deplus, R., & Fuks, F. (2014) · The EMBO Journal · doi:10.15252/embj.201488290 · Cited by 118
The role of 5-hydroxymethylcytosine in human cancer
Pfeifer, G. P., Xiong, W., Hahn, M. A., & Jin, S. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1896-7 · Cited by 118
5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy
Vasanthakumar, A., & Godley, L. A. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.02.009 · Cited by 116
TET Family Proteins: Oxidation Activity, Interacting Molecules, and Functions in Diseases
Lu, X., Zhao, B. S., & He, C. (2015) · Chemical Reviews · doi:10.1021/cr500470n · Cited by 118
Epigenomes as therapeutic targets
Hamm, C. A., & Costa, F. F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.003 · Cited by 114
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Puig, I., Tenbaum, S. P., Chicote, I., Arqués, O., Martínez‐Quintanilla, J., Cuesta-Borràs, E., Ramírez, L., Gonzalo, P., Soto, A., Aguilar, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96393 · Cited by 113
In vitro assays and techniques utilized in anticancer drug discovery
Ediriweera, M. K., Tennekoon, K. H., & Samarakoon, S. R. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3658 · Cited by 116
Crichton, J. H., Dunican, D. S., MacLennan, M., Meehan, R. R., & Adams, I. R. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1468-0 · Cited by 115
Putiri, E. L., Tiedemann, R. L., Thompson, J. J., Liu, C., Ho, T. H., Choi, J.-H., & Robertson, K. D. (2014) · Genome biology · doi:10.1186/gb-2014-15-6-r81 · Cited by 111
Self-citationTan, L., Xiong, L., Xu, W., Wu, F., Huang, N., Xu, Y., Kong, L., Zheng, L., Schwartz, L., Shi, Y., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt091 · Cited by 115
Self-citationOstrowski, S. M., & Fisher, D. E. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.08.010 · Cited by 115
Metadata
- Authors
- Lian, C. G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., Lee, C.-W., Hu, D., Lian, B. Q., Kleffel, S., Yang, Y., Neiswender, J., Khorasani, A. J., Fang, R., Lezcano, C., Duncan, L. M., Scolyer, R. A., Thompson, J. F., Kakavand, H., Houvras, Y., Zon, L. I., Mihm, M. C., Kaiser, U. B., Schatton, T., Woda, B. A., Murphy, G. F., & Shi, Y. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Fudan University (CN)
- University of Massachusetts Chan Medical School (US)
- Ziopharm Oncology (United States) (US)
- Harvard University (US)
- The University of Sydney (AU)
- Corresponding author
- Shi, Yujiang G.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 150
- Issue
- 6
- Pages
- 1135-1146
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3770275
- OpenAlex
- W2029746613
- Cited by
- 789
- References
- 40
- Citations by year
- 2026: 16 · 2025: 29 · 2024: 34 · 2023: 32 · 2022: 53 · 2021: 56 · 2020: 53 · 2019: 60 · 2018: 67 · 2017: 75 · 2016: 76 · 2015: 73 · 2014: 86 · 2013: 71 · 2012: 8
- FWCI
- 30.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 380 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Ministry of Education of the People's Republic of China
- Fudan University
- National Institutes of Health (5P50CA093683-09)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- 5-hydroxymethylcytosine, melanoma, DNA methylation, TET enzymes, IDH2, TET2, epigenetic cancer therapy, tumor suppressor, prognostic factors, melanoma progression
- MeSH terms
- Cytosine, DNA-Binding Proteins, Humans, Isocitrate Dehydrogenase, Melanocytes, Melanoma, Nevus, Proto-Oncogene Proteins, Gene Expression Regulation, Neoplastic, Epigenesis, Genetic, 5-Methylcytosine, Dioxygenases, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
